Feature|Articles|October 8, 2026

Fast Is Not the Same as Trustworthy: The Data Standing Behind an Effective AI Answer

Exploring the emergence of agentic ecosystems in transforming data accessibility and ensuring reliable answers reach the people making decisions while there is still a choice to make.

Pharmaceutical companies are not short on market data. Most hold more than their teams can practically use, including sales trends, promotional spend and effort, health care professional (HCP) sentiment, competitive intelligence, pipeline intelligence, loss-of-exclusivity timelines and forecasts.1 Over the past two years, the industry conversation has focused on what artificial intelligence (AI) could do with all that data. While that question has largely been settled, a more difficult one has emerged: Can the answers be trusted?

Related to this article

How QMM Can Help the C-Suite See a  $100 Million Problem Early
A passing FDA inspection tells pharma senior leadership very little about whether the next significant revenue vulnerability is already taking shape. But continuous, AI-enabled quality management maturity (QMM) has the potential to do so months before the issue reaches the realm of P&L.